RBC Capital Maintains Outperform on Zynex, Lowers Price Target to $11
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh maintains an Outperform rating on Zynex (NASDAQ:ZYXI) but lowers the price target from $12 to $11.
October 08, 2024 | 6:58 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
RBC Capital continues to see potential in Zynex with an Outperform rating, but has adjusted the price target down from $12 to $11, indicating a slightly less optimistic outlook.
The Outperform rating suggests continued confidence in Zynex's performance, but the lowered price target reflects a tempered expectation of growth. This mixed signal may result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100